Pepdox
Studies
Peptides
Calculator
In adults with T2D and ASCVD, tirzepatide was noninferior to dulaglutide for a composite CV outcome at a median 4 y. | Pepdox
Home
/
Search
/
PMID 42081805
In adults with T2D and ASCVD, tirzepatide was noninferior to dulaglutide for a composite CV outcome at a median 4 y.
Annals of internal medicine
2026
PMID: 42081805
View on PubMed
DOI: 10.7326/ANNALS-26-00991-JC
Tirzepatide
Abstract
GIM/FP/GP:[Formula: see text] Cardiology:[Formula: see text] Endocrinology:[Formula: see text].
Authors
Karagiannis, Thomas; Avgerinos, Ioannis; Tsapas, Apostolos